Your browser doesn't support javascript.
loading
Optimizing Antitumor Efficacy and Adverse Effects of Pegylated Liposomal Doxorubicin by Scheduled Plasmapheresis: Impact of Timing and Dosing.
Ngoune, Romeo; Contini, Christine; Hoffmann, Michael M; von Elverfeldt, Dominik; Winkler, Karl; Putz, Gerhard.
Afiliação
  • Ngoune R; Medical Center - University of Freiburg, Faculty of Medicine, Institute for Clinical Chemistry and Laboratory Medicine, Freiburg, Germany.
  • Contini C; Medical Center - University of Freiburg, Faculty of Medicine, Institute for Clinical Chemistry and Laboratory Medicine, Freiburg, Germany.
  • Hoffmann MM; Medical Center - University of Freiburg, Faculty of Medicine, Institute for Clinical Chemistry and Laboratory Medicine, Freiburg, Germany.
  • von Elverfeldt D; Medical Center - University of Freiburg, Faculty of Medicine, Department of Diagnostic Radiology Medical Physics, Freiburg, Germany.
  • Winkler K; Medical Center - University of Freiburg, Faculty of Medicine, Institute for Clinical Chemistry and Laboratory Medicine, Freiburg, Germany.
  • Putz G; Medical Center - University of Freiburg, Faculty of Medicine, Institute for Clinical Chemistry and Laboratory Medicine, Freiburg, Germany.
Curr Drug Deliv ; 15(9): 1261-1270, 2018.
Article em En | MEDLINE | ID: mdl-29779479
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doxorrubicina / Plasmaferese / Antibióticos Antineoplásicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doxorrubicina / Plasmaferese / Antibióticos Antineoplásicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article